Sowell Financial Services’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,126
Closed -$117K 563
2021
Q1
$117K Sell
2,126
-883
-29% -$43.7K ﹤0.01% 1297
2020
Q4
$130K Buy
3,009
+2,999
+29,990% +$119K 0.01% 1048
2020
Q3
$0 Sell
10
-90
-90% -$3.94K ﹤0.01% 2500
2020
Q2
$5K Hold
100
﹤0.01% 1878
2020
Q1
$4K Hold
100
﹤0.01% 1862
2019
Q4
$5K Sell
100
-30
-23% -$1.13K ﹤0.01% 1887
2019
Q3
$4K Buy
+130
New +$5.38K ﹤0.01% 1804
2017
Q1
Sell
-10
Closed 262
2016
Q4
$0 Buy
+10
New +$525 ﹤0.01% 642

Other funds holding AGIO

Sowell Financial Services's AGIO Position: Q2 2021 in Review

Sowell Financial Services sold out of Agios Pharmaceuticals (AGIO) in Q2 2021, closing a stake of 2,126 shares — an estimated $117K sold.

Sowell Financial Services first reported a position in AGIO in Q4 2016 and held it in 8 quarters. The position peaked at $130K in Q4 2020. 186 funds tracked by Wall St. Rank hold AGIO as of Q2 2021.

  • Sowell Financial Services reported no remaining Agios Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 2,126 Agios Pharmaceuticals shares in Q2 2021, an estimated $117K.
  • Sowell Financial Services first reported a position in Agios Pharmaceuticals in Q4 2016 and held it in 8 quarters.
  • Sowell Financial Services's Agios Pharmaceuticals position peaked at $130K in Q4 2020.
  • 186 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.